These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26433072)

  • 21. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of Subcutaneous White Adipose Tissue Inflammatory Environment Modelling in Non-Insulin Resistant Obesity and Responses to Omega-3 Fatty Acids - A Double Blind, Randomised Clinical Trial.
    Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Antoun E; Lillycrop KA; Calder PC
    Front Immunol; 2022; 13():922654. PubMed ID: 35958557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues.
    Li CJ; Fang QH; Liu ML; Lin JN
    Theranostics; 2020; 10(16):7422-7435. PubMed ID: 32642003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary flaxseed oil reduces adipocyte size, adipose monocyte chemoattractant protein-1 levels and T-cell infiltration in obese, insulin-resistant rats.
    Baranowski M; Enns J; Blewett H; Yakandawala U; Zahradka P; Taylor CG
    Cytokine; 2012 Aug; 59(2):382-91. PubMed ID: 22592037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
    Sharma AM; Staels B
    J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for sphingolipids in the pathophysiology of obesity-induced inflammation.
    Bikman BT
    Cell Mol Life Sci; 2012 Jul; 69(13):2135-46. PubMed ID: 22294100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism.
    Lim J; Iyer A; Liu L; Suen JY; Lohman RJ; Seow V; Yau MK; Brown L; Fairlie DP
    FASEB J; 2013 Dec; 27(12):4757-67. PubMed ID: 23964081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fat as an endocrine organ: relationship to the metabolic syndrome.
    Hutley L; Prins JB
    Am J Med Sci; 2005 Dec; 330(6):280-9. PubMed ID: 16355012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance.
    Goossens GH
    Physiol Behav; 2008 May; 94(2):206-18. PubMed ID: 18037457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women.
    Corbould A; Bhathal PS; Dixon JB; O'Brien PE
    Metab Syndr Relat Disord; 2014 Aug; 12(6):311-9. PubMed ID: 24819229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipokines in inflammation, insulin resistance and cardiovascular disease.
    Li ZY; Wang P; Miao CY
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):888-96. PubMed ID: 21910745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endocrine function of adipose tissue: an update.
    Ronti T; Lupattelli G; Mannarino E
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):355-65. PubMed ID: 16584505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism of obesity-induced 'metabolic' tissue remodeling.
    Tanaka M; Itoh M; Ogawa Y; Suganami T
    J Diabetes Investig; 2018 Mar; 9(2):256-261. PubMed ID: 29086488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease.
    Wu CL; Zhao SP; Yu BL
    Biol Rev Camb Philos Soc; 2015 May; 90(2):367-76. PubMed ID: 24834836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipose tissue inflammation in insulin resistance: review of mechanisms mediating anti-inflammatory effects of omega-3 polyunsaturated fatty acids.
    Pahlavani M; Ramalho T; Koboziev I; LeMieux MJ; Jayarathne S; Ramalingam L; Filgueiras LR; Moustaid-Moussa N
    J Investig Med; 2017 Oct; 65(7):1021-1027. PubMed ID: 28954844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid signaling in adipose tissue: Connecting inflammation & metabolism.
    Masoodi M; Kuda O; Rossmeisl M; Flachs P; Kopecky J
    Biochim Biophys Acta; 2015 Apr; 1851(4):503-18. PubMed ID: 25311170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of chronic inflammation in adipose tissue in the pathophysiology of obesity].
    Suganami T; Ogawa Y
    Nihon Rinsho; 2013 Feb; 71(2):225-30. PubMed ID: 23631197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.